Norges Bank Ginkgo Bioworks Holdings, Inc. Transaction History

Norges Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $4.38 Million - $18.1 Million	15,627,824 New	15,627,824 $5.16 Million
Q4 2023 Feb 09, 2024	BUY	$1.26 - $1.79 $18.6 Million - $26.4 Million	14,773,078 New	14,773,078 $25 Million
Q3 2023 Nov 13, 2024	BUY	$1.61 - $2.54 $21.9 Million - $34.6 Million	13,610,982 New	13,610,982 $24.6 Million
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $309,614 - $488,459	-192,307 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$1.14 - $1.95 $6.92 Million - $11.8 Million	-6,070,836 Reduced 38.85%	9,556,988 $17.8 Million
Q1 2023 May 15, 2024	BUY	$1.2 - $2.19 $7.63 Million - $13.9 Million	6,354,603 New	6,354,603 $8.45 Million
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $12.8 Million - $27.7 Million	7,873,652 New	7,873,652 $13.3 Million
Q3 2022 Nov 13, 2023	BUY	$0.73 - $3.74 $140,384 - $719,228	192,307 New	192,307 $599,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.